{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:40Z","timestamp":1793371000541,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bulcan.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:30:26Z","timestamp":1790890226000},"page":"1267-1277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effets des phytoestrog\u00e8nes sur le pronostic et des marqueurs hormonaux du cancer du sein\u00a0: une revue syst\u00e9matique d\u2019essais cliniques randomis\u00e9s"],"prefix":"10.1016","volume":"113","author":[{"given":"Laurence","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Diorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2026.08.003_bib0195","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36\u00a0cancers in 185\u00a0countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0200","series-title":"SEER*Explorer: an interactive website for SEER cancer statistics [Internet]","year":"2026"},{"issue":"7","key":"10.1016\/j.bulcan.2026.08.003_bib0205","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms24076834","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.bulcan.2026.08.003_bib0210","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/ptr.7861","article-title":"A review on phytoestrogens: current status and future direction","volume":"37","author":"Patra","year":"2023","journal-title":"Phytother Res"},{"issue":"14","key":"10.1016\/j.bulcan.2026.08.003_bib0215","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.3390\/ijms26146973","article-title":"Daidzein and genistein: natural phytoestrogens with potential applications in hormone replacement therapy","volume":"26","author":"Intharuksa","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0220","doi-asserted-by":"crossref","first-page":"108762","DOI":"10.1016\/j.maturitas.2025.108762","article-title":"Oestrogen receptor beta in breast cancer prognosis and treatment","volume":"203","author":"Bozovic","year":"2025","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0225","doi-asserted-by":"crossref","first-page":"pkad104","DOI":"10.1093\/jncics\/pkad104","article-title":"Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies","volume":"8","author":"van Die","year":"2024","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/nutrit\/nuaa043","article-title":"Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis","volume":"79","author":"Micek","year":"2021","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/01635581.2023.2279220","article-title":"Dietary isoflavone intake and breast cancer prognosis: a prospective analysis and meta-analysis","volume":"76","author":"Song","year":"2024","journal-title":"Nutr Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2026.08.003_bib0240","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ijc.34321","article-title":"Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis","volume":"152","author":"Becerra-Tomas","year":"2023","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2026.08.003_bib0245","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.7150\/jca.55477","article-title":"Lignans intake and enterolactone concentration and prognosis of breast cancer: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"issue":"21","key":"10.1016\/j.bulcan.2026.08.003_bib0250","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.3390\/cancers13215329","article-title":"Dietary factors and breast cancer prognosis among breast cancer survivors: a systematic review and meta-analysis of cohort studies","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0255","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","author":"Higgins","year":"2024"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015\u00a0statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0265","first-page":"75","article-title":"Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status","volume":"30","author":"Coburn","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0270","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"12_Supplement","key":"10.1016\/j.bulcan.2026.08.003_bib0280","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS24-P5-08-20","article-title":"Abstract P5-08-20: Comparative study of the gut microbiome of newly diagnosed postmenopausal breast cancer patients and healthy controls, and pilot study on the acceptability of soy milk in the patient group [Abstract]","volume":"31","author":"Takada","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0285","series-title":"Clinical trial of the action of isoflavones in breast neoplasia: administration prior to mastectomy or lumpectomy \u2013 a pilot study [Internet]","author":"Kumar","year":"2002"},{"issue":"2","key":"10.1016\/j.bulcan.2026.08.003_bib0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1940-6207.CAPR-11-0251","article-title":"Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial","volume":"5","author":"Khan","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.bulcan.2026.08.003_bib0295","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/1078-0432.CCR-23-1615","article-title":"The effect of diet on breast cancer recurrence: the DIANA-5\u00a0randomized trial","volume":"30","author":"Berrino","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-020-05534-4","article-title":"Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen","volume":"180","author":"Ferraris","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.003_bib0305","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/acm.2005.11.1067","article-title":"Short-term soy and probiotic supplementation does not markedly affect concentrations of reproductive hormones in postmenopausal women with and without histories of breast cancer","volume":"11","author":"Nettleton","year":"2005","journal-title":"J Altern Complement Med"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.003_bib0310","first-page":"1213","article-title":"A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients","volume":"101","author":"Nikander","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bulcan.2026.08.003_bib0315","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1210\/jc.2003-030362","article-title":"Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women","volume":"88","author":"Nikander","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bulcan.2026.08.003_bib0320","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2003-031166","article-title":"Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer","volume":"89","author":"Nikander","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0325","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fertnstert.2004.09.003","article-title":"Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women","volume":"83","author":"Nikander","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0330","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1210\/jc.2003-032229","article-title":"Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women","volume":"89","author":"Nikander","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0335","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.gme.0000191210.13115.90","article-title":"Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones","volume":"13","author":"Tormala","year":"2006","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.bulcan.2026.08.003_bib0340","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.gme.0000236935.51325.4d","article-title":"Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women","volume":"14","author":"Badeau","year":"2007","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s13668-025-00640-5","article-title":"A review of the clinical and epidemiologic evidence relevant to the impact of postdiagnosis isoflavone intake on breast cancer outcomes","volume":"14","author":"Messina","year":"2025","journal-title":"Curr Nutr Rep"},{"issue":"2","key":"10.1016\/j.bulcan.2026.08.003_bib0350","first-page":"133","article-title":"Comprehensive review of isoflavones and lignans in the prophylaxis and treatment of breast cancer","volume":"45","author":"Tulacz","year":"2026","journal-title":"J Am Nutr Assoc"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.003_bib0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3945\/ajcn.2009.28573","article-title":"Meta-analyses of lignans and enterolignans in relation to breast cancer risk","volume":"92","author":"Buck","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0360","doi-asserted-by":"crossref","first-page":"106539","DOI":"10.1016\/j.jsbmb.2024.106539","article-title":"Metabolism of endogenous and exogenous estrogens in women","volume":"242","author":"Stanczyk","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0365","series-title":"Could soy products affect my risk of cancer? [Internet]","author":"Mogor","year":"2017"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0370","unstructured":"Soci\u00e9t\u00e9 canadienne du cancer (SCC). Bien manger apr\u00e8s un cancer du sein [Internet]. Ottawa (ON): SCC, 2025. [Consult\u00e9 13\u00a0mai 2026]. Disponible \u00e0\u00a0: https:\/\/cancer.ca\/fr\/cancer-information\/cancer-types\/breast\/supportive-care\/eating-well-after-breast-cancer."},{"key":"10.1016\/j.bulcan.2026.08.003_bib0375","series-title":"Soy and cancer risk: our experts\u2019 advice [Internet]","author":"American Cancer Society","year":"2025"},{"key":"10.1016\/j.bulcan.2026.08.003_bib0190","series-title":"Soy and cancer: myths and misconceptions [Internet]","year":"2024"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126004029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126004029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:26:26Z","timestamp":1793370386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126004029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0007455126004029"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.08.003","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effets des phytoestrog\u00e8nes sur le pronostic et des marqueurs hormonaux du cancer du sein\u00a0: une revue syst\u00e9matique d\u2019essais cliniques randomis\u00e9s","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}